Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011 (2011), Article ID 289389, 5 pages
http://dx.doi.org/10.1155/2011/289389
Case Report

Detrusor Arreflexia as an End Stage of Neurogenic Bladder in HAM/TSP?

Serviço de Imunologia, Hospital Universitário Proffessor Edgard Santos, 5 Andar, Rua João das Botas S/N, Canela, Salvador CEP 40110-160, BA, Brazil

Received 19 October 2010; Accepted 22 February 2011

Academic Editor: Edgar M. Carvalho

Copyright © 2011 Matheus Tannus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Nakamura, “HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy,” Folia Neuropathologica, vol. 47, no. 2, pp. 182–194, 2009. View at Google Scholar · View at Scopus
  2. C. Hlela, S. Shepperd, N. P. Khumalo, and G. P. Taylor, “The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown,” AIDS Reviews, vol. 11, no. 4, pp. 205–214, 2009. View at Google Scholar · View at Scopus
  3. G. De The and R. Bomford, “An HTLV-I vaccine: why, how, for whom?” AIDS Research and Human Retroviruses, vol. 9, no. 5, pp. 381–386, 1993. View at Google Scholar · View at Scopus
  4. J. R. Orland, J. Engstrom, J. Fridey et al., “Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study,” Neurology, vol. 61, no. 11, pp. 1588–1594, 2003. View at Google Scholar · View at Scopus
  5. H. H. Biswas, J. W. Engstrom, Z. Kaidarova et al., “Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy,” Neurology, vol. 73, no. 10, pp. 781–789, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Cooper, M. S. van der Loeff, and G. P. Taylor, “The neurology of HTLV-1 infection,” Practical Neurology, vol. 9, no. 1, pp. 16–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Oliveira, N. M. De Castro, and E. M. Carvalho, “Urinary and sexual manifestations of patients infected by HTLV-I,” Clinics, vol. 62, no. 2, pp. 191–196, 2007. View at Google Scholar · View at Scopus
  8. N. M. de Castro, D. M. Freitas, W. Rodrigues Jr., A. Muniz, P. Oliveira, and E. M. Carvalho, “Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals,” International Brazilian Journal of Urology, vol. 33, no. 2, pp. 238–244, 2007. View at Google Scholar
  9. S. Komine, H. Yoshida, C. Fujiyama, and Z. Masaki, “Voiding dysfunction in patients with human T-lymphotropic-virus-type-1-associated myelopathy,” Urologia Internationalis, vol. 47, supplement 1, pp. 67–68, 1991. View at Google Scholar · View at Scopus
  10. A. Imamura, T. Kitagawa, Y. Ohi, and M. Osami, “Clinical manifestations of human T-cell lymphotrophic virus type-I-associated myelopathy and vesicopathy,” Urologia Internationalis, vol. 46, pp. 149–153, 1991. View at Google Scholar
  11. Medical Research Council, “Aids to examination of the peripheral nervous system,” London: Memorandum no. London: her Majestry's Stationary Office, 1976.
  12. R. W. Bohannon and M. B. Smith, “Interrater reliability of a modified Ashworth scale of muscle spasticity,” Physical Therapy, vol. 67, no. 2, pp. 206–207, 1987. View at Google Scholar · View at Scopus
  13. W. Campbell, DeJong's The Neurologic Examination, Lippincott Williams and Wilkins, Baltimore, Md, USA, 6th edition, 2005.
  14. J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1452, 1983. View at Google Scholar · View at Scopus
  15. M. Nakagawa, K. Nakahara, Y. Maruyama et al., “Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis,” Journal of Neurovirology, vol. 2, no. 5, pp. 345–355, 1996. View at Google Scholar · View at Scopus
  16. C. L. M. Lima, G. Rabolini, M. Menna-Barreto, E. B. Dos Santos, and W. J. Koff, “Urodynamic alterations in patients with HTLV-1 infection,” International Brazilian Journal of Urology, vol. 28, no. 5, pp. 452–456, 2002. View at Google Scholar · View at Scopus
  17. H. Yamashita and J. Kumazawa, “Voiding dysfunction: patients with human T-lymphotropic-virus-type-1-associated myelopathy,” Urologia Internationalis, vol. 47, supplement 1, pp. 69–71, 1991. View at Google Scholar · View at Scopus
  18. S. Komine, K. Yoshida, H. Yamashita, and Z. Masaki, “Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM),” Paraplegia, vol. 27, no. 3, pp. 217–221, 1989. View at Google Scholar · View at Scopus